QLT Inc. (NASDAQ: QLTI) announced that results from an investigator-sponsored Phase II study, in patients with subfoveal choroidal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE